Prostate Oncology Specialists,Inc. Company Profile

03:58 EDT 24th March 2018 | BioPortfolio

Prostate Oncology Specialists is a medical group exclusively devoted to caring for men with prostate cancer. We have vast experience diagnosing and treating prostate cancer because 100% of our time is focused on managing men with this disease. Our physicians are board certified in both medical oncology and internal medicine and have made significant contributions to the scientific advancement in this field


4676 Admiralty Way, Suite 101
Marina del Rey
United States of America


Phone: 310.827.7707
Fax: 310.574.4002

News Articles [1231 Associated News Articles listed on BioPortfolio]

Structured prostate MRI reports boost clinical impact

BI-RADS, developed by the American College of Radiology

Rutgers researcher receives $1 million grant for international prostate cancer study

A $1 million grant from Gateway for Cancer Research will help Rutgers Cancer Institute of New Jersey Urologic Oncology Chief Isaac Yi Kim, MD, PhD, MBA evaluate the impact of surgically removing the p...

Higher-dose RT does not improve survival but reduces recurrence risk for prostate cancer patients

Results of a recent NRG Oncology study, NRG Oncology/RTOG 0126, show that high-dose radiotherapy did not improve survival for men with intermediate-risk prostate cancer but did improve biochemical con...

Sleep Specialists and Non-Sleep Specialists Alike Can Provide Effective Apnea Care

Non-sleep specialists can diagnose and manage obstructive sleep apnea as well as specialists can, suggests a review in the Annals of Internal Medicine. However...

Prostate Cancer Care Is 'Changing Rapidly': ESMO 2017

Exciting research presented at ESMO 2017 will likely affect clinical practice in metastatic prostate cancer, says Dr Johann de Bono. Medscape Oncology

Genetic Mutations and Prostate Cancer: Screening Recommendations

In light of recently published data, Dr David Graham suggests potential approaches to prostate cancer screening that incorporate genetic test results. Medscape Oncology

Optimizing Treatment for Castration-Resistant Prostate Cancer

Individualizing castration-resistant prostate cancer therapy depends not only on drug profiles but also on patient-related factors. Experts offer a way through the data to reach a clinical decision. ...

Medical News Today: Metastatic prostate cancer: What you need to know

Prostate cancer occurs when the cells in the prostate grow uncontrollably. Metastatic prostate cancer means the cancer has spread beyond the prostate.

PubMed Articles [2595 Associated PubMed Articles listed on BioPortfolio]

Decreasing suicide risk among patients with prostate cancer: Implications for depression, erectile dysfunction, and suicidal ideation screening.

Prostate cancer is the most common malignancy among males, accounting for 19% of cancers, and the third most common cancer-related cause of death. Suicide rates in the United States have increased amo...

Intratumoural evolutionary landscape of high-risk prostate cancer: the PROGENY study of genomic and immune parameters.

Intratumoural heterogeneity (ITH) is well recognised in prostate cancer (PC), but its role in high-risk disease is uncertain. A prospective, single-arm, translational study using targeted multiregion ...

Prostate cancers that 'Wnt' respond to abiraterone.

Effect of Standard vs Dose-Escalated Radiation Therapy for Patients With Intermediate-Risk Prostate Cancer: The NRG Oncology RTOG 0126 Randomized Clinical Trial.

Optimizing radiation therapy techniques for localized prostate cancer can affect patient outcomes. Dose escalation improves biochemical control, but no prior trials were powered to detect overall surv...

Age at diagnosis and prostate cancer treatment and prognosis: a population-based cohort study.

Old age at prostate cancer diagnosis has been associated with poor prognosis in several studies. We aimed to investigate the association between age at diagnosis and prognosis, and if it is independen...

Clinical Trials [2735 Associated Clinical Trials listed on BioPortfolio]

Stereotactic Prostate Adaptive Radiotherapy Utilising Kilovoltage Intrafraction Monitoring

The SPARK trial is testing the use of Kilovoltage Intrafraction Monitoring in prostate cancer patients being treated with Stereotactic Prostate Adaptive Radiotherapy. The researchers expe...

Collection of Blood From Patients With Prostate Cancer

Background: - It is not fully understood why prostate cancer in some men becomes androgen-independent (no longer responds to anti-androgen medication), but genetics likely plays a...

PALLiON - PALLiative Care In ONcology

A major concern in today's oncology is the complexity of treatment that increases costs. A main contributor is the increasing use of chemo- and radiotherapy during end of life (EoL: the la...

Hypofractionated SBRT For Prostate Cancer

The purpose of this study is to determine, in both low-risk and intermediate-risk cohorts, the rates of acute and late grade 3 or higher gastrointestinal and genitourinary toxicity observe...

Trimodal (18)F-choline-PET/mpMRI/TRUS Targeted Prostate Biopsies

Prostate cancer is the first cancer in humans (25%). The most widely used tracer in oncology, the 18-Fluoro DeoxyGlucose does not allow the study of prostatic neoplasia. On the other hand,...

Companies [1309 Associated Companies listed on BioPortfolio]

Prostate Oncology Specialists,Inc.

Prostate Oncology Specialists is a medical group exclusively devoted to caring for men with prostate cancer. We have vast experience diagnosing and treating prostate cancer because 100% of our time is...

Prostate Oncology Specialists, Inc.

According to the American Cancer Society, prostate cancer is the most common non-skin cancer in the United States and the third most common cancer worldwide. More than two million men in the United St...

Texas Oncology

Texas Oncology delivers high-quality cancer care with leading-edge technology and advanced treatment and therapy options available to help patients achieve “More breakthrough...

Minomic International Ltd

Minomic International Ltd is an Australian immuno-oncology company specialising in therapeutics and diagnostics for prostate cancer and other cancers. Minomic has developed the in...

Prostate Cancer Foundation

The Prostate Cancer Foundation (PCF) is the world’s largest philanthropic source of support for accelerating the world’s most promising research for discovering better t...

More Information about "Prostate Oncology Specialists,Inc." on BioPortfolio

We have published hundreds of Prostate Oncology Specialists,Inc. news stories on BioPortfolio along with dozens of Prostate Oncology Specialists,Inc. Clinical Trials and PubMed Articles about Prostate Oncology Specialists,Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Prostate Oncology Specialists,Inc. Companies in our database. You can also find out about relevant Prostate Oncology Specialists,Inc. Drugs and Medications on this site too.

Quick Search


Relevant Topic

  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Corporate Database Quicklinks

Searches Linking to this Company Record